| Literature DB >> 29474911 |
Daniel S Kermany1, Michael Goldbaum2, Wenjia Cai2, Carolina C S Valentim2, Huiying Liang3, Sally L Baxter2, Alex McKeown4, Ge Yang2, Xiaokang Wu5, Fangbing Yan5, Justin Dong3, Made K Prasadha2, Jacqueline Pei1, Magdalene Y L Ting2, Jie Zhu6, Christina Li2, Sierra Hewett1, Jason Dong3, Ian Ziyar2, Alexander Shi2, Runze Zhang2, Lianghong Zheng7, Rui Hou8, William Shi2, Xin Fu1, Yaou Duan2, Viet A N Huu1, Cindy Wen2, Edward D Zhang1, Charlotte L Zhang1, Oulan Li1, Xiaobo Wang9, Michael A Singer10, Xiaodong Sun11, Jie Xu12, Ali Tafreshi4, M Anthony Lewis13, Huimin Xia3, Kang Zhang14.
Abstract
The implementation of clinical-decision support algorithms for medical imaging faces challenges with reliability and interpretability. Here, we establish a diagnostic tool based on a deep-learning framework for the screening of patients with common treatable blinding retinal diseases. Our framework utilizes transfer learning, which trains a neural network with a fraction of the data of conventional approaches. Applying this approach to a dataset of optical coherence tomography images, we demonstrate performance comparable to that of human experts in classifying age-related macular degeneration and diabetic macular edema. We also provide a more transparent and interpretable diagnosis by highlighting the regions recognized by the neural network. We further demonstrate the general applicability of our AI system for diagnosis of pediatric pneumonia using chest X-ray images. This tool may ultimately aid in expediting the diagnosis and referral of these treatable conditions, thereby facilitating earlier treatment, resulting in improved clinical outcomes. VIDEO ABSTRACT.Entities:
Keywords: age-related macular degeneration; artificial intelligence; choroidal neovascularization; deep learning; diabetic macular edema; diabetic retinopathy; optical coherence tomography; pneumonia; screening; transfer learning
Mesh:
Year: 2018 PMID: 29474911 DOI: 10.1016/j.cell.2018.02.010
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582